CoreCap Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
CoreCap Advisors's BTAL Position: Q2 2026 in Review
CoreCap Advisors opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 3,273 shares worth $36.5K. The stake represents ﹤0.01% of the portfolio and ranks #1549 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in BTAL as recently as Q4 2022.
CoreCap Advisors first reported a position in BTAL in Q3 2022 and has held it in 3 quarters since. The position peaked at $2.43M in Q4 2022. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- CoreCap Advisors held 3,273 shares of AGF US Market Neutral Anti-Beta Fund worth $36.5K as of Q2 2026.
- AGF US Market Neutral Anti-Beta Fund was a new CoreCap Advisors position in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1549 holding.
- CoreCap Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and has held it in 3 quarters since.
- CoreCap Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $2.43M in Q4 2022.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.